All KURA Content

Analysis

Kura Oncology Posts $0.92/Share Q4 Loss as KOMZIFTI Launch Delivers $2.1M in Initial Revenue

Kura Oncology reports wider Q4 loss of $0.92/share as KOMZIFTI launch generates $2.1M in first weeks; payers implement step edits favoring drug over competitor.

March 6, 20264 min read

Breaking News

Kura Oncology Reports $0.92 Q4 Loss Even as KOMZIFTI Debuts With $2.1M in Sales

Kura Oncology posted a $0.92 per share loss in Q4 2025 as KOMZIFTI generated $2.1M in debut sales, with payers implementing step edits favoring the…

March 6, 20262 min read

Kura Oncology Inc (KURA) Q2 2022 Earnings conference

Kura Oncology Inc (NASDAQ: KURA) Q2 2022 Earnings Conference

August 1, 20221 min read

Kura Oncology Inc (KURA) Q1 2022 Earnings conference

Kura Oncology Inc (NASDAQ: KURA) Q1 2022 Earnings Conference

May 2, 20221 min read

Kura Oncology Inc (KURA) Kura Oncology to Report Fourth Quarter and Full Year 2021 Financial Results

Kura Oncology Inc (NASDAQ: KURA) Q4 2021 Earnings Conference

February 23, 20221 min read

Kura Oncology, inc (KURA) Kura Oncology to Report Third Quarter 2021 Financial Results

Kura Oncology, inc (NASDAQ: KURA) Q3 2021 Earnings Conference

November 8, 20211 min read

Kura Oncology Inc (KURA) Kura Oncology to Report Second Quarter 2021 Financial Results

Kura Oncology Inc (NASDAQ: KURA) Q2 2021 Earnings Conference

August 9, 20211 min read